Terms: = Endocrine gland cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Prognosis
7 results:
1. Specific human leukocyte antigen class I genotypes predict prognosis in resected pancreatic adenocarcinoma: a retrospective cohort study.
Wen C; Zhang L; Yang Y; Jin Y; Ren D; Zhang Z; Zou S; Li F; Sun H; Jin J; Lu X; Xie J; Cheng D; Xu Z; Chen H; Mao B; Zhang J; Wang J; Deng X; Peng C; Li H; Jiang C; Lin L; Zhang H; Chen H; Shen B; Zhan Q
Int J Surg; 2023 Jul; 109(7):1941-1952. PubMed ID: 37026827
[TBL] [Abstract] [Full Text] [Related]
2. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
3. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs).
Cai L; Michelakos T; Deshpande V; Arora KS; Yamada T; Ting DT; Taylor MS; Castillo CF; Warshaw AL; Lillemoe KD; Ferrone S; Ferrone CR
Clin Cancer Res; 2019 Apr; 25(8):2644-2655. PubMed ID: 30670493
[TBL] [Abstract] [Full Text] [Related]
4. Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
Suzuki N; Hazama S; Iguchi H; Uesugi K; Tanaka H; Hirakawa K; Aruga A; Hatori T; Ishizaki H; Umeda Y; Fujiwara T; Ikemoto T; Shimada M; Yoshimatsu K; Shimizu R; Hayashi H; Sakata K; Takenouchi H; Matsui H; Shindo Y; Iida M; Koki Y; Arima H; Furukawa H; Ueno T; Yoshino S; Nakamura Y; Oka M; Nagano H
Cancer Sci; 2017 Jan; 108(1):73-80. PubMed ID: 27783849
[TBL] [Abstract] [Full Text] [Related]
5. Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer.
Leffers N; Gooden MJ; Mokhova AA; Kast WM; Boezen HM; Ten Hoor KA; Hollema H; Daemen T; van der Zee AG; Nijman HW
Gynecol Oncol; 2009 May; 113(2):256-63. PubMed ID: 19243813
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
[TBL] [Abstract] [Full Text] [Related]
7. Distant metastases in ovarian carcinoma.
Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
[TBL] [Abstract] [Full Text] [Related]
